Moreover, the downstream target SOCS3 has been implicated in depression.[42] Therefore, we speculate that the JAK‐STAT pathway may exert its regulatory effects on post‐stroke depression through the modulation of SOCS3 or Ptpn6. Here, SOCS3 is linked to depressive symptom measurement.